Hematocrit and plasma albumin levels difference may be a potential biomarker to discriminate preeclampsia and eclampsia in patients with hypertensive disorders of pregnancy

详细信息    查看全文

• 作者：Dong-Mei Dai^a ; Jing Cao^a ; Hong-Mei Yang^b ; Hai-Mei Sun^a ; Yu Su^a ; Yuan-Yuan Chen^a ; Xiao Fang^a ; Wang-Bin Xu^a ; ^{xwbyn@126.com}
• 关键词：Hypertensive disorders of pregnancy (HDP) ; Eclampsia ; Preeclampsia ; Hematocrit (HCT) ; Albumin (ALB)
• 刊名：Clinica Chimica Acta
• 出版年：2017
• 出版时间：January 2017
• 年：2017
• 卷：464
• 期：Complete
• 页码：218-222
• 全文大小：331 K
• 卷排序：464

文摘

Patients with or without HDP were analyzed for the HCT and the ALB alterations Preeclampsia/eclampsia patients had a significantly higher mean HCT-ALB value. The difference of HCT-ALB might be a potential biomarker for preeclampsia/eclampsia.